Ypsomed Holding AG
LSE:0QLQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Ypsomed Holding AG (0QLQ) under the Base Case is CHF per share.
Compared with the current market price of 436.7 CHF, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Ypsomed Does
Ypsomed Holding AG makes drug delivery devices that help patients inject medicines at home. Its core products include insulin pens, pen needles, autoinjectors, and pump systems for people who need regular injections, especially diabetes patients and other chronic-care users. The company also develops and sells connected devices and digital tools that help patients track treatment and use their medicines correctly.
- Headquarters
- Switzerland CH
- Employees
- 2 025
- IPO date
- Sep 22, 2004
Balance Sheet
Recent Events
Latest Earnings Call
After a strong first half, Ypsomed raised its full-year outlook for Delivery Systems sales growth and EBIT.
Open the earnings call- Stock, next trading day
- +5.6%
Past 12 months
Continue 0QLQ Research
Decided on Ypsomed Holding? Get an email when 0QLQ reaches the price you’d buy at. Free with an account.
Other Ypsomed Holding listings
What is the Intrinsic Value of one 0QLQ stock?
The intrinsic value for
Ypsomed Holding AG (0QLQ) under the Base Case is CHF.
Is 0QLQ stock undervalued or overvalued?
Compared with the current market price of 436.7 CHF, the stock appears .